Extracorporeal shock wave therapy with low-energy flux density inhibits hypertrophic scar formation in an animal model

Zhao,Jing-Chun; Zhang,Bo-Ru; Hong,Lei; Shi,Kai; Wu,Wei-Wei; Yu,Jia-Ao

doi:10.3892/ijmm.2018.3434

Extracorporeal shock wave therapy with low-energy flux density inhibits hypertrophic scar formation in an animal model

Authors:
- Jing-Chun Zhao
- Bo-Ru Zhang
- Lei Hong
- Kai Shi
- Wei-Wei Wu
- Jia-Ao Yu
View Affiliations

Affiliations: Burns and Plastic Reconstruction Unit, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: January 29, 2018 https://doi.org/10.3892/ijmm.2018.3434
Pages: 1931-1938
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypertrophic scar is characterized by excessive deposits of collagen during skin wound healing, which could become a challenge to clinicians. This study assessed the effects of the extracorporeal shock wave therapy (ESWT) on hypertrophic scar formation and the underlying gene regulation. A rabbit ear hypertrophic scar model was generated and randomly divided into three groups: L-ESWT group to receive L-ESWT (energy flux density of 0.1 mJ/mm2), H-ESWT (energy flux density of 0.2 mJ/mm2) and sham ESWT group (S-ESWT). Hypertrophic scar tissues were then collected and stained with hematoxylin and eosin (H&E) and Masson's trichrome staining, respectively, to assess scar elevation index (SEI), fibroblast density and collagen fiber arrangement. Expression of cell proliferation marker proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin (α-SMA) were assessed using RT-PCR and immunohistochemistry in hypertrophic scar tissues. H&E staining sections showed significant reduction of SEI and fibroblast density in both ESWT treatment groups compared to S-ESWT, but there was no dramatic difference between L-ESWT and H-ESWT groups. Masson's trichrome staining showed that collagen fibers were more slender and broader and oriented in parallel to skin surface after administration of ESWT compared to control tissues. At the gene level, PCNA‑positive fibroblasts and α-SMA-positive myofibroblasts were significantly decreased after L-ESWT or H-ESWT compared to the controls. Furthermore, there was no significant difference in expression of PCNA mRNA between L-ESWT or H-ESWT and S-ESWT, whereas expression of α-SMA mRNA significantly decreased in L-ESWT compared to that of H-ESWT and S-ESWT (P=0.002 and P=0.030, respectively). In conclusion, L-ESWT could be effective on suppression of hypertrophic scar formation by inhibition of scar elevation index and fibroblast density as well as α-SMA expression in hypertrophic scar tissues of the rabbit model.

View Figures

View References

1	Stadelmann WK, Digenis AG and Tobin GR: Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg. 176(Suppl 2A): 26S–38S. 1998. View Article : Google Scholar : PubMed/NCBI
2	Midwood KS, Williams LV and Schwarzbauer JE: Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 36:1031–1037. 2004. View Article : Google Scholar : PubMed/NCBI
3	Gauglitz GG, Korting HC, Pavicic T, Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 17:113–125. 2011. View Article : Google Scholar :
4	Nedelec B, Shankowsky H, Scott PG, Ghahary A and Tredget EE: Myofibroblasts and apoptosis in human hypertrophic scars: the effect of interferon-alpha2b. Surgery. 130:798–808. 2001. View Article : Google Scholar : PubMed/NCBI
5	Slemp AE and Kirschner RE: Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 18:396–402. 2006. View Article : Google Scholar : PubMed/NCBI
6	Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, Ghahary A and Tredget EE: Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen. 13:398–404. 2005. View Article : Google Scholar : PubMed/NCBI
7	Ali SS, Hajrah NH, Ayuob NN, Moshref SS and Abuzinadah OA: Morphological and morphometric study of cultured fibroblast from treated and untreated abnormal scar. Saudi Med J. 31:874–881. 2010.PubMed/NCBI
8	Williams CC and De Groote S: Clinical inquiry: what treatment is best for hypertrophic scars and keloids. J Fam Pract. 60:757–758. 2011.PubMed/NCBI
9	Shridharani SM, Magarakis M, Manson PN, Singh NK, Basdag B and Rosson GD: The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: a review. Ann Plast Surg. 64:355–361. 2010. View Article : Google Scholar : PubMed/NCBI
10	Dymarek R, Halski T, Ptaszkowski K, Slupska L, Rosinczuk J and Taradaj J: Extracorporeal shock wave therapy as an adjunct wound treatment: a systematic review of the literature. Ostomy Wound Manage. 60:26–39. 2014.PubMed/NCBI
11	Chaussy C, Brendel W and Schmiedt E: Extracorporeally induced destruction of kidney stones by shock waves. Lancet. 2:1265–1268. 1980. View Article : Google Scholar : PubMed/NCBI
12	Rassweiler J, Rassweiler MC, Frede T and Alken P: Extracorporeal shock wave lithotripsy: an opinion on its future. Indian J Urol. 30:73–79. 2014. View Article : Google Scholar : PubMed/NCBI
13	Valchanou VD and Michailov P: High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop. 15:181–184. 1991. View Article : Google Scholar : PubMed/NCBI
14	Maffulli G, Hemmings S and Maffulli N: Assessment of the effectiveness of extracorporeal shock wave therapy (ESWT) for soft tissue injuries (ASSERT): an online database protocol. Transl Med UniSa. 10:46–51. 2014.PubMed/NCBI
15	Mittermayr R, Hartinger J, Antonic V, Meinl A, Pfeifer S, Stojadinovic A, Schaden W and Redl H: Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg. 253:1024–1032. 2011. View Article : Google Scholar : PubMed/NCBI
16	Zhao JC, Xian CJ and Yu JA: Advancement in the research of effect of extracorporeal shock wave therapy on wound angiogenesis. Chin J Inj Repair Wound Healing. 9:80–84. 2014.
17	Zhao J, Xue Y, Yu J, Shi K, Xian C and Zhou X: Advances in the research of mechanism of enhancement of wound healing with extracorporeal shock wave therapy. Zhonghua Shao Shang Za Zhi. 31:315–317. 2015.In Chinese. PubMed/NCBI
18	Speed C: A systematic review of shockwave therapies in soft tissue conditions: focusing on the evidence. Br J Sports Med. 48:1538–1542. 2014. View Article : Google Scholar
19	Goertz O, Lauer H, Hirsch T, Ring A, Lehnhardt M, Langer S, Steinau HU and Hauser J: Extracorporeal shock waves improve angiogenesis after full thickness burn. Burns. 38:1010–1018. 2012. View Article : Google Scholar : PubMed/NCBI
20	Kloeters O, Tandara A and Mustoe TA: Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen. 15(Suppl 1): S40–S45. 2007. View Article : Google Scholar
21	Zhou M, Li LH, Peng H, Li R, Feng CC, Xu WD, Leng RX, Pan HF and Ye DQ: Decreased ITGAM and FcγRIIIA mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Med. 14:269–274. 2014. View Article : Google Scholar
22	Wang CJ, Ko JY, Chan YS, Weng LH and Hsu SL: Extra-corporeal shockwave for chronic patellar tendinopathy. Am J Sports Med. 35:972–978. 2007. View Article : Google Scholar : PubMed/NCBI
23	Yin MC, Ye J, Yao M, Cui XJ, Xia Y, Shen QX, Tong ZY, Wu XQ, Ma JM and Mo W: Is extracorporeal shock wave therapy clinical efficacy for relief of chronic, recalcitrant plantar fasciitis? A systematic review and meta-analysis of randomized placebo or active-treatment controlled trials. Arch Phys Med Rehabil. 95:1585–1593. 2014. View Article : Google Scholar : PubMed/NCBI
24	Thiele S, Thiele R and Gerdesmeyer L: Lateral epicondylitis: this is still a main indication for extracorporeal shockwave therapy. Int J Surg. 24(Pt B): 165–170. 2015. View Article : Google Scholar : PubMed/NCBI
25	Wang CJ, Cheng JH, Kuo YR, Schaden W and Mittermayr R: Extracorporeal shockwave therapy in diabetic foot ulcers. Int J Surg. 24(Pt B): 207–209. 2015. View Article : Google Scholar : PubMed/NCBI
26	Wang CJ, Ko JY, Kuo YR and Yang YJ: Molecular changes in diabetic foot ulcers. Diabetes Res Clin Pract. 94:105–110. 2011. View Article : Google Scholar : PubMed/NCBI
27	Waugh CM, Morrissey D, Jones E, Riley GP, Langberg H and Screen HR: In vivo biological response to extracorporeal shockwave therapy in human tendinopathy. Eur Cell Mater. 29:268–280. 2015. View Article : Google Scholar : PubMed/NCBI
28	Fioramonti P, Cigna E, Onesti MG, Fino P, Fallico N and Scuderi N: Extracorporeal shock wave therapy for the management of burn scars. Dermatol Surg. 38:778–782. 2012. View Article : Google Scholar : PubMed/NCBI
29	Saggini R, Saggini A, Spagnoli AM, Dodaj I, Cigna E, Maruccia M, Soda G, Bellomo RG and Scuderi N: Extracorporeal shock wave therapy: an emerging treatment modality for retracting scars of the hands. Ultrasound Med Biol. 42:185–195. 2016. View Article : Google Scholar
30	Yagmur C, Akaishi S, Ogawa R and Guneren E: Mechanical receptor-related mechanisms in scar management: a review and hypothesis. Plast Reconstr Surg. 126:426–434. 2010. View Article : Google Scholar : PubMed/NCBI
31	Bravo R and Macdonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol. 105:1549–1554. 1987. View Article : Google Scholar : PubMed/NCBI
32	Moldovan GL, Pfander B and Jentsch S: PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007. View Article : Google Scholar : PubMed/NCBI
33	Nedelec B, Ghahary A, Scott PG and Tredget EE: Control of wound contraction. Basic and clinical features. Hand Clin. 16:289–302. 2000.PubMed/NCBI
34	Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Vallé CA and Roy M: Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol. 198:350–358. 2004. View Article : Google Scholar : PubMed/NCBI
35	Lim MJ, Ahn J, Yi JY, Kim MH, Son AR, Lee SL, Lim DS, Kim SS, Kang MA, Han Y, et al: Induction of galectin-1 by TGF-β1 accelerates fibrosis through enhancing nuclear retention of Smad2. Exp Cell Res. 326:125–135. 2014. View Article : Google Scholar : PubMed/NCBI